TransDermal Technologies, Inc. (TTI) The company specializes in leveraging its patented rapid-acting, drug-specific, liquid sprayed-on transdermal delivery technology to develop effective alternative delivery systems for valued drugs. No other company can offer similar, consumer-friendly, dosing-flexible solutions. The Company's platform technology is a patented physio-chemical and mathematical process for designing a system capable of temporarily neutralizing the skin's barrier function, enabling delivery to or through the skin, to local tissues or to the whole body, of a very wide range of compounds with pharmaceutical or cosmetic value.